Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jun 24;34(24):e173.
doi: 10.3346/jkms.2019.34.e173.

A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome

Affiliations
Case Reports

A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome

Sena Kang et al. J Korean Med Sci. .

Abstract

D-penicillamine has been reported to cause antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis presenting as rapidly progressive glomerulonephritis or pulmonary-renal syndrome mostly in adults. We report a pediatric case of D-penicillamine induced ANCA-associated vasculitis that manifests as a pulmonary-renal syndrome with a mild renal manifestation. A 13-year-old girl who has been taking D-penicillamine for five years under the diagnosis of Wilson disease visited the emergency room because of hemoptysis and dyspnea. She had diffuse pulmonary hemorrhage, microscopic hematuria, and proteinuria. Myeloperoxidase ANCA was positive, and a renal biopsy revealed pauci-immune crescentic glomerulonephritis. Under the diagnosis of D-penicillamine-induced ANCA-associated vasculitis, D-penicillamine was switched to trientine, and the patient was treated with plasmapheresis, glucocorticoid, cyclophosphamide, and mycophenolate mofetil. Pulmonary hemorrhage improved rapidly followed by the disappearance of the hematuria and proteinuria five months later.

Keywords: Antineutrophil Cytoplasmic Antibodies; Child; Penicillamine; Pulmonary-Renal Syndrome; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose

Figures

Fig. 1
Fig. 1. Chest radiologic findings of the patient. (A) Bilateral extensive patchy consolidation at the plain film and (B) the multifocal patchy ground-glass opacity at chest computed tomography suggest diffuse pulmonary hemorrhage.
Fig. 2
Fig. 2. Photomicrograph of the kidney biopsy. (A) Crescent formation is observed in 39% of the total 41 glomeruli by the light microscopy (PAS, ×40). (B) A representative crescent (arrow) is shown at a high power magnification (PAS, ×400).
PAS = periodic acid–Schiff.

Similar articles

Cited by

References

    1. Hutton HL, Holdsworth SR, Kitching AR. ANCA-associated vasculitis: pathogenesis, models, and preclinical testing. Semin Nephrol. 2017;37(5):418–435. - PubMed
    1. Hogan JJ, Markowitz GS, Radhakrishnan J. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015;10(7):1300–1310. - PMC - PubMed
    1. Banfi G, Imbasciati E, Guerra L, Mihatsch MJ, Ponticelli C. Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis. Nephron. 1983;33(1):56–60. - PubMed
    1. Sadjadi SA, Seelig MS, Berger AR, Milstoc M. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine. Am J Nephrol. 1985;5(3):212–216. - PubMed
    1. Williams AJ, Fordham JN, Barnes CG, Goodwin FJ. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis. 1986;45(1):82–84. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts